News
Lennar repurchased 4.7 million shares for $517 million during the quarter. It ended Q2 with $5.4 billion in liquidity and a ...
Truist said Hinge has posted a 45% compound annual growth rate in billings and 55% in revenue from 2022 to 2024, supported by ...
Beyond that, I think Trump’s announcement provides investors with a fresh incentive to turn their attention to global trade, ...
UBS began coverage of several packaged food companies with a cautious outlook, citing softening consumer trends and questions ...
TD Cowen upgraded Celsius Holdings (NASDAQ: CELH) to Buy and raised its price target to $55 in a note to clients on Monday, ...
Wells Fargo upgraded Wix (NASDAQ: WIX).com to Overweight from Equal Weight on growing confidence that the website builder can ...
Iran has asked Qatar, Saudi Arabia, and Oman to urge U.S. President Donald Trump to influence Israel to agree to an immediate ...
RBC Capital Markets began coverage of Knife River Corp and Martin Marietta Material, noting difference in in margin profiles ...
S&P Global Ratings downgraded LGI Homes Inc. (NASDAQ: LGIH) to ’B+’ from ’BB-’ on June 16, 2025, citing weaker-than-expected earnings that have kept leverage metrics above the downgrade trigger. The ...
Oppenheimer analysts raised their price target for Outperform-rated Meta Platforms (NASDAQ: META) shares to $775 from $665 in ...
Investing.com -- CVS Health (NYSE: CVS) stock rose 1% on Wednesday after Bloomberg reported that Medicare Pharmacy Benefit Manager (PBM) limits were stripped from the Senate version of the tax bill.
Leerink Partners began coverage on three of the largest medical technology companies on Monday, assigning bullish ratings to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results